A Transdiagnostic Sleep and Circadian Treatment to Improve Community SMI Outcomes
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Psychiatric, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/27/2017 |
| Start Date: | May 2015 |
| End Date: | May 2019 |
Mental illness is often severe, chronic and difficult to treat. The sleep disturbance
commonly experienced by individuals with a severe mental illness reduces capacity to function
and contributes to key symptoms. This study seeks to determine if an intervention to improve
sleep can improve functioning and reduce symptoms and impairment. We will conduct this study
in community mental health centers to ensure that the results contribute to closing the
worrisome gap between research and practice and to ensure that the findings are generalizable
to the real world.
commonly experienced by individuals with a severe mental illness reduces capacity to function
and contributes to key symptoms. This study seeks to determine if an intervention to improve
sleep can improve functioning and reduce symptoms and impairment. We will conduct this study
in community mental health centers to ensure that the results contribute to closing the
worrisome gap between research and practice and to ensure that the findings are generalizable
to the real world.
Despite advances in treatment, severe mental illness (SMI) remains common, chronic and
difficult to treat. SMI is defined as having at least one mental disorder that lasts for
12-months and leads to substantial life interference. Sleep and circadian dysfunctions are
among the most prominent correlates of SMI, yet have been minimally studied in ways that
reflect the complexity of the sleep problems experienced by people with SMI. In SMI, sleep
and circadian dysfunction undermines affect regulation, cognitive function and physical
health, predicts onset and worsening of symptoms and is often chronic even with
evidence-based SMI treatment. Prior treatment studies have been disorder-focused—they have
treated a specific sleep problem (e.g., insomnia) in a specific diagnostic group (e.g.,
depression). However, real life sleep and circadian problems are not so neatly categorized,
particularly in SMI where features of insomnia overlap with hypersomnia, delayed sleep phase
and irregular sleep-wake schedules. Accordingly, we aim to test the hypothesis that a
Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) will improve
functional impairment, disorder-focused symptoms and sleep and circadian functioning. We will
recruit participants across DSM diagnoses and across common sleep and circadian problems. The
elements of TranS-C are efficacious across SMI in research settings with research-based
providers. The next step is to test TranS-C in community settings with community-based
providers. Accordingly, we propose to conduct an 'efficacy in the real world' randomized
controlled trial within Alameda County Behavioral Health Care Services (ACBHCS), the
community mental health center (CMHC) for Alameda County. We will recruit 120 adults
diagnosed with SMI and sleep and circadian dysfunction within ACBHCS. Individuals will be
randomly allocated to TranS-C (n = 60) or 6-months of Usual Care followed by Delayed
Treatment with TranS-C (UC-DT; n = 60). TranS-C is modularized and delivered across eight to
twelve 50-minute, weekly, individual sessions. All participants will be assessed before,
immediately following treatment (ie. 9-14 weeks later) and again 6 months later.
difficult to treat. SMI is defined as having at least one mental disorder that lasts for
12-months and leads to substantial life interference. Sleep and circadian dysfunctions are
among the most prominent correlates of SMI, yet have been minimally studied in ways that
reflect the complexity of the sleep problems experienced by people with SMI. In SMI, sleep
and circadian dysfunction undermines affect regulation, cognitive function and physical
health, predicts onset and worsening of symptoms and is often chronic even with
evidence-based SMI treatment. Prior treatment studies have been disorder-focused—they have
treated a specific sleep problem (e.g., insomnia) in a specific diagnostic group (e.g.,
depression). However, real life sleep and circadian problems are not so neatly categorized,
particularly in SMI where features of insomnia overlap with hypersomnia, delayed sleep phase
and irregular sleep-wake schedules. Accordingly, we aim to test the hypothesis that a
Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) will improve
functional impairment, disorder-focused symptoms and sleep and circadian functioning. We will
recruit participants across DSM diagnoses and across common sleep and circadian problems. The
elements of TranS-C are efficacious across SMI in research settings with research-based
providers. The next step is to test TranS-C in community settings with community-based
providers. Accordingly, we propose to conduct an 'efficacy in the real world' randomized
controlled trial within Alameda County Behavioral Health Care Services (ACBHCS), the
community mental health center (CMHC) for Alameda County. We will recruit 120 adults
diagnosed with SMI and sleep and circadian dysfunction within ACBHCS. Individuals will be
randomly allocated to TranS-C (n = 60) or 6-months of Usual Care followed by Delayed
Treatment with TranS-C (UC-DT; n = 60). TranS-C is modularized and delivered across eight to
twelve 50-minute, weekly, individual sessions. All participants will be assessed before,
immediately following treatment (ie. 9-14 weeks later) and again 6 months later.
Inclusion Criteria:
- Age 18+ years
- English language fluency
- Presence of at least one DSM-V mental disorder for 12 months
- One or more of the following sleep or circadian problems for 3 month as assessed with
the Sleep and Circadian Problems Interview:
- ≥30 mins to get to sleep , 3 or more nights per week
- Waking in the middle of the night for ≥30 minutes, 3 or more nights per week
- Obtaining less than 6 hours of sleep per night, 3 or more nights per week
- Obtaining more than 9 hours of sleep per 24 hour period (i.e., nighttime sleep
plus daytime napping), 3 or more nights per week
- More than 2.78 hours of variability in sleep-wake schedule across one week
- Bedtime later than 2 am, 3 or more nights per week
- Guaranteed bed to sleep in for the duration of the treatment phase
- Receiving care for SMI at ACBHCS and consent to regular communications between
research team and psychiatrist and/or case manager
Exclusion Criteria:
- Presence of an active and progressive physical illness or neurological degenerative
disease AND/OR substance abuse/dependence making participation in the study
unfeasible.
- Current serious suicide risk (assessed by our staff, a case manager or psychiatrist)
or homicide risk (assessed by our staff, a case manager or psychiatrist)
- Night shift work >2 nights per week in the past 3 months
- Pregnancy or breast-feeding
- Not able/willing to participate in and/or complete the pre-treatment assessments
We found this trial at
1
site
Click here to add this to my saved trials
